Please login to the form below

Not currently logged in
Email:
Password:

Genocea Biosciences

This page shows the latest Genocea Biosciences news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic vaccine designed to reduce the duration and severity of

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    outbreaks. Last year, Sanofi set up an alliance with Immune Design to develop a therapeutic vaccine for HSV-2 based on their two vaccine candidates, while Genocea Biosciences, Agenus and Tomegavax

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics